PMID: 6397451Jan 1, 1984Paper

Central nervous system infections in the immunocompromised host

Infection
D Armstrong

Abstract

Central nervous system (CNS) infections in the immunocompromised host are predictable according to the arm of the immune defense which is most defective. A limited number of organisms with a tendency to cause CNS infections will take advantage of the different types of immune defects. Signs and symptoms of CNS infection are often quite subtle in the immunocompromised host because of the diminished inflammatory response. Serologic responses may not be as reliable as in a normal host. Aggressive diagnostic approaches are often necessary, including early brain biopsy and abscess drainage. Aggressive therapy is often also necessary, including multiple potentially toxic antibiotics and devices to deliver them, such as indwelling intraventricular reservoirs. The role of the third generation cephalosporins is still not clear, and certainly they should not be used alone to treat aerobic gram-negative rod meningitis in neutropenic patients. Patients with the acquired immune deficiency syndrome (AIDS) have developed CNS infections with familiar agents producing familiar syndromes. The main CNS infection, however, is a subacute encephalitis and the causative agent remains undocumented.

References

Nov 1, 1973·Medicine·N L ChernikJ B Posner
Mar 1, 1984·Neurology·S A LukesD Armstrong
Oct 15, 1983·Cancer·T B Hakes, D Armstrong
Jan 1, 1984·Annals of Internal Medicine·B WongC W Lerner
Jan 1, 1982·Annual Review of Medicine·D Armstrong, B Wong

❮ Previous
Next ❯

Citations

Jul 1, 1989·Diagnostic Microbiology and Infectious Disease·D K Stein, A M Sugar
May 1, 1994·European Journal of Cancer. Part B, Oral Oncology·J H MeurmanL Teerenhovi
Apr 4, 2013·The Journal of Infection·Jesper D GunstOle S Søgaard
Jul 1, 1996·Transactions of the Royal Society of Tropical Medicine and Hygiene·V M SrivastavaM Chandy
Jan 1, 1989·Annals of Emergency Medicine·M Callaham
Jul 26, 2003·Seminars in Pediatric Infectious Diseases·Xavier Sáez-Llorens
Jul 13, 2004·Clinical Psychology Review·Janine G WalkerGeoffrey O Littlejohn
Jan 1, 1988·Annals of Neurology·R M LevyM L Rosenblum
Jul 1, 1995·Journal of Child Neurology·I Brook
Dec 1, 1984·The Journal of Experimental Zoology·M A OttingerH Opel
Nov 24, 1998·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·H Tsai, L A Bobek
Feb 1, 2008·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Jacob H HollisBrian J Oldfield
Nov 25, 2003·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Tsuyoshi Saito, Hideaki Soya

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.